Erythropoietin Receptor Signaling through STAT3 Is Required for Glioma Stem Cell Maintenance

Recombinant erythropoietin (EPO) is a growth factor used in the treatment of chemotherapy-induced anemia, but recent studies suggest that EPO may accelerate cancer growth. Although several cancers express EPO receptors (EPORs), the mechanism by which EPOR promotes tumor growth remains poorly underst...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cao, Yiting, Lathia, Justin D., Eyler, Christine E., Wu, Qiulian, Li, Zhizhong, Wang, Hui, McLendon, Roger E., Hjelmeland, Anita B., Rich, Jeremy N.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2010
Gaiak:
Original Articles and Short Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2906804/
https://ncbi.nlm.nih.gov/pubmed/20657792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601909356352
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak